Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1984-8-16
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
E
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0193-7758
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
KIE
pubmed:authorsComplete
Y
pubmed:pagination
1-5
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11649526-Biomedical Research, pubmed-meshheading:11649526-Conflict of Interest, pubmed-meshheading:11649526-Drug Industry, pubmed-meshheading:11649526-Ethics Committees, pubmed-meshheading:11649526-Ethics Committees, Research, pubmed-meshheading:11649526-Federal Government, pubmed-meshheading:11649526-Financial Support, pubmed-meshheading:11649526-Financing, Government, pubmed-meshheading:11649526-Government, pubmed-meshheading:11649526-Human Experimentation, pubmed-meshheading:11649526-Humans, pubmed-meshheading:11649526-Industry, pubmed-meshheading:11649526-Patient Selection, pubmed-meshheading:11649526-Pharmaceutical Preparations, pubmed-meshheading:11649526-Public Policy, pubmed-meshheading:11649526-Research, pubmed-meshheading:11649526-Research Design, pubmed-meshheading:11649526-Research Personnel, pubmed-meshheading:11649526-Research Subjects, pubmed-meshheading:11649526-Scientific Misconduct, pubmed-meshheading:11649526-Universities
pubmed:articleTitle
In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
pubmed:publicationType
Journal Article